Treatment for canine leishmaniasis exists in Brazilian vaccine

November 14, 2018

A vaccine used to prevent dogs from contracting the deadly, parasitic disease canine leishmaniasis also can be used to treat currently infected dogs, found Morris Animal Foundation-funded researchers at the University of Iowa, providing a new avenue of treatment for millions of infected dogs globally.

Canine leishmaniosis (CanL) is a major zoonotic disease enzootic in more than 70 countries and has recently emerged in the United States. CanL also is a concern in countries where imported disease creates a veterinary and public health problem.

The study, recently published in the journal Vaccine, provided the first clinical trial of the vaccine LeishTec™ in infected dogs. The vaccine is commercially available in Brazil, and is frequently prescribed by veterinarians there, though it had never been tested to see if it was not only safe but could fight the disease in already infected dogs.

"Too many dogs die every year because of this terrible disease, and we've figured out all the things that could go wrong with the body during disease. I wanted to start coming up with tools to make things go right," said Dr. Christine Petersen, University of Iowa, Associate Professor of Epidemiology. "Usually vaccines prevent infections, but some, like the rabies post-exposure prophylactic vaccine, can be used after infection. We were happy to prove this was the case with LeishTec."

The team tested the vaccine in eight states on more than 400 dogs, almost all foxhounds, as they are one of the breeds mostly likely to carry the disease in North America. Researchers split the dogs into control and experimental groups, vaccinated the experimental groups three times in six weeks and then checked each dog every three months for the next year to determine the vaccine's effectiveness. They discovered it was not only safe to give the vaccine to already infected dogs, but it also minimized disease in the experimental group.

Canine leishmaniasis is caused by the parasite Leishmania infantum and is typically transmitted by sand fly bites in tropical countries. It also can be spread through mothers to their pups. In the United States, it's believed many foxhounds were born with CanL through breeding with imported hounds from endemic areas. Symptoms can range from skin sores and weight loss to blindness and kidney failure. Treatment is available, but most dogs die from the disease despite therapy.

There isn't enough data to determine how many dogs in the United States suffer from the disease, but Dr. Petersen says it impacts about 20 percent of dogs in Southern Europe and is creeping northward. The disease also is widespread in Brazil, where millions of infected dogs are euthanized every year so they don't, through the bite of sand flies, lead to more infected humans.

"This is an important study that is going to make a big difference in canine health globally," said Dr. Kelly Diehl, Morris Animal Foundation Interim Vice President of Scientific Programs. "We now have a new tool in the toolbox to control this disease and give countless dogs longer, healthier lives."

Morris Animal Foundation

Related Vaccine Articles from Brightsurf:

Who should get the COVID-19 vaccine first?
Nineteen global health experts from around the world have proposed a new, three-phase plan for vaccine distribution -- called the Fair Priority Model -- which aims to reduce premature deaths and other irreversible health consequences from COVID-19.

Breakthrough with cancer vaccine
Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers.

How to improve the pneumococcus vaccine
Pneumococcus kills 1 million children annually according to the World Health Organization.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
In a new study, published April 7 in mBio, researchers from the University of Iowa and the University of Georgia demonstrate that a new vaccine fully protects mice against a lethal dose of MERS, a close cousin of COVID-19.

Coronavirus Vaccine: Where are we and what's next? (video)
You might have heard that COVID-19 vaccine trials are underway in Seattle.

Why isn't there a vaccine for staph?
A study from Washington University School of Medicine in St.

Exposing vaccine hesitant to real-life pain of diseases makes them more pro-vaccine
New research from Brigham Young University professors finds there is a better way to help increase support for vaccinations: Expose people to the pain and suffering caused by vaccine-preventable diseases instead of trying to combat people with vaccine facts.

Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.

On the horizon: An acne vaccine
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.

Read More: Vaccine News and Vaccine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to